Back
Viking Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
VKTX
Viking Therapeutics
Last Price:
51.43
Seasonality Move:
50.47%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.24 | Sell |
| 20-day SMA: | 64.06 | Sell |
| 50-day SMA: | 64.16 | Sell |
| 200-day SMA: | 61.94 | Sell |
| 8-day EMA: | 54.51 | Sell |
| 20-day EMA: | 59.86 | Sell |
| 50-day EMA: | 62.22 | Sell |
| 200-day EMA: | 55.66 | Sell |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.04 | Sell |
| Relative Strength Index (14 RSI): | 35.16 | Sell |
| Chaikin Money Flow: | -503260 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.72 - 72.24) | Sell |
| Bollinger Bands (100): | (54.05 - 67.19) | Sell |
Viking Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 51.53 while VKTX 8-day simple moving average is 54.24, which is a Sell signal.
- The stock price of VKTX is 51.53 while Viking Therapeutics 20-day SMA is 64.06, which makes it a Sell.
- Viking Therapeutics 50-day simple moving average is 64.16 while VKTX share price is 51.53, making it a Sell technically.
- VKTX stock price is 51.53 and Viking Therapeutics 200-day simple moving average is 61.94, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
37
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a Sell
The current Viking Therapeutics [VKTX] share price is $51.53. The Score for VKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
5.74B
Price in USD:
51.53
Share Volume:
3.5M
Viking Therapeutics 52-Week Range
52-Week High:
99.41
52-Week Low:
11.21
Sell
37
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?
The Viking Therapeutics stock price is 51.53 USD today. -
Will VKTX stock go up or go down?
Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viking Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
- Viking Therapeutics share price is 51.53 while VKTX 8-day exponential moving average is 54.51, which is a Sell signal.
- The stock price of VKTX is 51.53 while Viking Therapeutics 20-day EMA is 59.86, which makes it a Sell.
- Viking Therapeutics 50-day exponential moving average is 62.22 while VKTX share price is 51.53, making it a Sell technically.
- VKTX stock price is 51.53 and Viking Therapeutics 200-day simple moving average is 55.66, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
- VKTX Moving Average Covergence Divergence (MACD) indicator is -4.04, suggesting Viking Therapeutics is a Sell
- Viking Therapeutics Relative Strength Index (RSI) is 35.16, which suggest Viking Therapeutics is oversold
- The Bollinger Bands (25) for Viking Therapeutics is (55.72 - 72.24), which suggest Viking Therapeutics is a Sell
- The Bollinger Bands (100) for Viking Therapeutics is (54.05 - 67.19), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.